AVITA Medical, Inc. (RCEL) Raw Materials (2018 - 2022)

AVITA Medical (RCEL) has reported Raw Materials for 5 consecutive years, with $1.1 million the latest figure, recorded in Q4 2022.

• For the quarter ending Q4 2022, Raw Materials fell 7.45% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2022 stood at $1.1 million (down 7.45% YoY), and the FY2022 full-year result was $1.1 million, down 7.45% from the prior year.
• Raw Materials fell to $1.1 million in Q4 2022 per RCEL's latest filing, from $1.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $1.2 million in Q4 2021 and bottomed at $589691.6 in Q2 2018.
• Historically, Raw Materials has averaged $913402.2 across 5 years, with a median of $964500.0 in 2020.
• The sharpest annual moves came in 2020 and 2022: Raw Materials jumped 55.57% in 2020, then slipped 7.45% in 2022.
• Over 5 years, Raw Materials stood at $589691.6 in 2018, then advanced by 3.23% to $608721.6 in 2019, then soared by 55.57% to $947000.0 in 2020, then rose by 29.04% to $1.2 million in 2021, then decreased by 7.45% to $1.1 million in 2022.
• According to Business Quant data, Raw Materials over the past three periods registered $1.1 million, $1.2 million, and $982000.0 for Q4 2022, Q4 2021, and Q2 2021 respectively.